New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root
Oncology February 18,2024
Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root
Oncology February 18,2024
Lethal cancer cells buddy up to survive

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28
Oncology February 18,2024
Lethal cancer cells buddy up to survive

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28
Oncology February 18,2024
Phase 1 study: New medicine extends terminally-ill cancer patients' lives

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague
Oncology February 18,2024
Phase 1 study: New medicine extends terminally-ill cancer patients' lives

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague
Oncology February 18,2024
Researchers identify innovative strategy with potential to enhance bowel cancer treatment

Researchers identify innovative strategy with potential to enhance bowel cancer treatment

by University of GalwayGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112475Researchers at University of Galway studying cell interactions in bowel cancer h
Oncology February 18,2024
Researchers identify innovative strategy with potential to enhance bowel cancer treatment

Researchers identify innovative strategy with potential to enhance bowel cancer treatment

by University of GalwayGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112475Researchers at University of Galway studying cell interactions in bowel cancer h
Oncology February 18,2024
Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

by eLifeCredit: Unsplash/CC0 Public DomainResearchers have revealed differences in cancer screening uptake during the pandemic according to people's sex, age, education, race and ethnicity.Th
Oncology February 18,2024
Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

by eLifeCredit: Unsplash/CC0 Public DomainResearchers have revealed differences in cancer screening uptake during the pandemic according to people's sex, age, education, race and ethnicity.Th
Oncology February 18,2024
Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing
Oncology February 18,2024
Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing
Oncology February 18,2024
Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt
Oncology February 18,2024
Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt
Oncology February 18,2024
Researchers develop novel approach for predicting resistance against cancer therapy

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi
Oncology February 18,2024
Researchers develop novel approach for predicting resistance against cancer therapy

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi
Oncology February 18,2024
Diverticular disease associated with cancer outside gastrointestinal tract

Diverticular disease associated with cancer outside gastrointestinal tract

by Karolinska InstitutetIllustration of bacteria in the human gut. Credit: Darryl Leja, National Human Genome Research Institute, National Institutes of HealthThrough the ESPRESSO cohort, researc
Oncology February 18,2024
Diverticular disease associated with cancer outside gastrointestinal tract

Diverticular disease associated with cancer outside gastrointestinal tract

by Karolinska InstitutetIllustration of bacteria in the human gut. Credit: Darryl Leja, National Human Genome Research Institute, National Institutes of HealthThrough the ESPRESSO cohort, researc
Oncology February 18,2024
Exercise testing detects silent cardiovascular dangers common in pediatric cancer survivors

Exercise testing detects silent cardiovascular dangers common in pediatric cancer survivors

by Nemours Children's Health SystemCredit: Pixabay/CC0 Public DomainCardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular problems in asymptomatic pediat
Oncology February 18,2024
Exercise testing detects silent cardiovascular dangers common in pediatric cancer survivors

Exercise testing detects silent cardiovascular dangers common in pediatric cancer survivors

by Nemours Children's Health SystemCredit: Pixabay/CC0 Public DomainCardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular problems in asymptomatic pediat
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com